Biopharma companies Gennao Bio and Juno Diagnostics raised a combined $65 million in Series A funding rounds.

Gene testing company Illumina won a jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a Roche subsidiary, of using patented prenatal testing technology without authorization.

Companies, trade groups and universities are among a broad coalition urging the U.S. Supreme Court to review the cancellation of a patent on a less risky form of prenatal testing.